Editorial Commentary
Long-term survivors of diffuse intrinsic pontine glioma (DIPG): myth or reality
Translational Cancer Research
2019;
8
(2)
:343-345
.
(30 April 2019)
Is transformed small cell lung cancer (SCLC) different from de novo SCLC?
Translational Cancer Research
2019;
8
(2)
:346-349
.
(30 April 2019)
Prognostic value of epigenomic profiling in lung cancer
Translational Cancer Research
2019;
8
(2)
:350-353
.
(30 April 2019)
Pretreatment prognostic factor for patients with human papillomavirus related oropharyngeal cancer
Translational Cancer Research
2019;
8
(2)
:354-356
.
(30 April 2019)
Original Article
Effects of ginsenoside Rg3 on apoptosis in A375.S2 melanoma cells
Translational Cancer Research
2019;
8
(2)
:357-366
.
(30 April 2019)
Circular RNA hsa_circ_0002124 promotes hepatocellular carcinoma cell proliferation through the MAPK pathway
Translational Cancer Research
2019;
8
(2)
:367-378
.
(30 April 2019)
NUMB knockdown enhanced the anti-tumor role of cisplatin on ovarian cancer cells by inhibiting cell proliferation and epithelial-mesenchymal transition
Translational Cancer Research
2019;
8
(2)
:379-388
.
(30 April 2019)
Concordance assessment of Watson for Oncology in breast cancer chemotherapy: first China experience
Translational Cancer Research
2019;
8
(2)
:389-401
.
(30 April 2019)
A mechanism of regucalcin knock-down in the promotion of proliferation and movement of human cervical cancer HeLa cells
Translational Cancer Research
2019;
8
(2)
:402-409
.
(30 April 2019)
Effect of receptor for hyaluronan-mediated motility inhibition on radiosensitivity of lung adenocarcinoma A549 cells
Translational Cancer Research
2019;
8
(2)
:410-421
.
(30 April 2019)
Risk factors and prediction of postoperative hypoparathyroidism among patients with papillary thyroid carcinoma
Translational Cancer Research
2019;
8
(2)
:422-428
.
(30 April 2019)
Multiplex fluorescent immunohistochemistry quantitatively analyses microvascular density (MVD) and the roles of TGF-β signalling in orchestrating angiogenesis in colorectal cancer
Translational Cancer Research
2019;
8
(2)
:429-438
.
(30 April 2019)
Microarray-based differential expression profiling of long noncoding RNAs and messenger RNAs in formalin-fixed paraffin-embedded human papillary thyroid carcinoma samples
Translational Cancer Research
2019;
8
(2)
:439-451
.
(30 April 2019)
The proteomic comparison of peripheral circulation-derived exosomes from the epithelial ovarian carcinoma (EOC) patients and non-EOC subjects
Translational Cancer Research
2019;
8
(2)
:452-465
.
(30 April 2019)
STX4 expression is associated with classification, clinical stage and lymphatic metastasis in ovarian cancer
Translational Cancer Research
2019;
8
(2)
:466-472
.
(30 April 2019)
Rapamycin downregulates NKG2D ligands in acute myeloid leukemia cells via an activation of the STAT3 pathway: a potential mechanism for rapamycin-induced immune escape in leukemia
Translational Cancer Research
2019;
8
(2)
:473-482
.
(30 April 2019)
BRCA1/2 mutation spectrum in Chinese early-onset breast cancer
Translational Cancer Research
2019;
8
(2)
:483-490
.
(30 April 2019)
Role of PRMT5 in bladder cancer: a comprehensive study
Translational Cancer Research
2019;
8
(2)
:491-498
.
(30 April 2019)
Human cancer cells compensate the genes unfavorable for translation by N6-methyladenosine modification and enhance their translation efficiency
Translational Cancer Research
2019;
8
(2)
:499-508
.
(30 April 2019)
Solamargine inhibits proliferation and promotes apoptosis of CM-319 human chordoma cells through suppression of notch pathway
Translational Cancer Research
2019;
8
(2)
:509-519
.
(30 April 2019)
Long non-coding RNA SNHG17 promotes gastric cancer progression by inhibiting P15 and P16
Translational Cancer Research
2019;
8
(2)
:520-531
.
(30 April 2019)
The high expression of TNF-α and NF-κB in tumor microenvironment predicts good prognosis of patients with BCLC-0-B hepatocellular carcinoma
Translational Cancer Research
2019;
8
(2)
:532-541
.
(30 April 2019)
miR-1290 inhibits chordoma cell proliferation and invasion by targeting Robo1
Translational Cancer Research
2019;
8
(2)
:542-551
.
(30 April 2019)
Circulating tumor DNA use in a community oncology practice
Translational Cancer Research
2019;
8
(2)
:552-556
.
(30 April 2019)
Interleukin 6 signaling maintains the stem-like properties of bladder cancer stem cells
Translational Cancer Research
2019;
8
(2)
:557-566
.
(30 April 2019)
ShRNA-mediated silencing of hTERT promote apoptosis and senescence in human ovarian cancer cells
Translational Cancer Research
2019;
8
(2)
:567-573
.
(30 April 2019)
Prognosis analysis of lobectomy and sublobar resection in patients ≥75 years old with pathological stage I invasive lung adenocarcinoma of ≤3 cm: a propensity score matching-based analysis
Translational Cancer Research
2019;
8
(2)
:574-582
.
(30 April 2019)
A novel mouse model of orthotopic extrahepatic cholangiocarcinoma confirmed with molecular imaging
Translational Cancer Research
2019;
8
(2)
:583-591
.
(30 April 2019)
Fumarate hydratase deficiency induces chronic myeloid leukemia progression
Translational Cancer Research
2019;
8
(2)
:592-602
.
(30 April 2019)
LncRNA SNHG1 correlates with higher T stage and worse overall survival, and promotes cell proliferation while reduces cell apoptosis in breast cancer
Translational Cancer Research
2019;
8
(2)
:603-613
.
(30 April 2019)
Prognostic value of primary tumor surgery in de novo stage IV breast cancer patients with different metastatic burdens: a propensity score-matched and population-based study
Translational Cancer Research
2019;
8
(2)
:614-625
.
(30 April 2019)
Cisplatin chemotherapy-induced miRNA-210 signaling inhibits hepatocellular carcinoma cell growth
Translational Cancer Research
2019;
8
(2)
:626-634
.
(30 April 2019)
The role of magnetic resonance imaging in detection and surgical treatment of breast intraductal papillomas
Translational Cancer Research
2019;
8
(2)
:635-646
.
(30 April 2019)
MiR-451 suppresses the growth, migration, and invasion of prostate cancer cells by targeting macrophage migration inhibitory factor
Translational Cancer Research
2019;
8
(2)
:647-654
.
(30 April 2019)
GSTM1 polymorphism in Oncotype DX assay is a potential predictive factor for taxane-based neoadjuvant chemotherapy in estrogen receptor-positive Chinese breast cancer patients
Translational Cancer Research
2019;
8
(2)
:655-663
.
(30 April 2019)
Identification of RRAS gene related to nasopharyngeal carcinoma based on pathway and network-based analyses
Translational Cancer Research
2019;
8
(2)
:664-675
.
(30 April 2019)
Review Article
The necessity of adjuvant radiotherapy for locally advanced gastric cancer in China
Translational Cancer Research
2019;
8
(2)
:676-682
.
(30 April 2019)
Brief Report
County poverty levels influence genome-wide DNA methylation profiles in African American and European American women
Translational Cancer Research
2019;
8
(2)
:683-692
.
(30 April 2019)
Case Report
Significant clinical response of advanced colorectal cancer to combination therapy involving capecitabine and adoptive cell transfer therapy: a case report
Translational Cancer Research
2019;
8
(2)
:693-698
.
(30 April 2019)
A case report of primary anaplastic large cell lymphoma arising from the trachea
Translational Cancer Research
2019;
8
(2)
:699-704
.
(30 April 2019)
Effectiveness of crizotinib in a patient with mesenchymal-epithelial transition overexpression/fluorescence in situ hybridization-negative/next-generation sequencing-negative advanced lung adenocarcinoma: a case report
Translational Cancer Research
2019;
8
(2)
:705-708
.
(30 April 2019)
Meet the Professor1
Nathan A. Berger: aging-cancer and obesity-cancer research require new mechanistic understandings
Translational Cancer Research
2019;
8
(2)
:709-712
.
(30 April 2019)
Erratum
Erratum to clinicopathological and theranostic analysis of 82 breast cancer patients older than 80 years
Translational Cancer Research
2019;
8
(2)
:713
.
(30 April 2019)
Retraction
Retraction: Cyclooxygenase-2 mediates puerarin to inhibit the invasion and metastasis of lung cancer A549 cells
Translational Cancer Research
2019;
8
(2)
:714
.
(30 April 2019)
Disclosure:
1. The series “Meet the Professor” was commissioned by the editorial office, Translational Cancer Research without any sponsorship or funding.
